Paris, France: Vaporizing a liquid formulation of CBD is associated with reduced cannabis/tobacco intake, according to data published in the journal Frontiers in Psychiatry. A team of French investigators assessed the impact of vaporized CBD on daily cannabis consumption patterns in a cohort of 20 daily consumers. Nearly all of the subjects in the study smoked cannabis mixed with tobacco in joints. Prior studies …
Quebec, Canada: Nearly one-third of patients living with chronic pain conditions acknowledge using cannabis for pain management, according to data published in the Canadian Journal of Pain. Canadian investigators assessed cannabis use trends in a cohort of 1,935 chronic pain patients residing in Quebec. (Cannabis products are legal for both medical purposes and for adult use in Canada.) Just over 30 percent of patients …
San Juan, Puerto Rico: Patients suffering from musculoskeletal pain disorders report obtaining significant relief following their use of medical cannabis products, according to data published in the Journal of the American Academy of Orthopedic Surgeons. A team of Puerto Rican investigators surveyed 184 patients with chronic pain conditions regarding their use of medical cannabis. (Lawmakers legalized patient access to certain cannabis preparations in 2015.) Respondents suffering …
Albuquerque, NM: The inhalation of cannabis is associated with perceived decreases in fatigue, according to data published in the journal Medical Cannabis and Cannabinoids. A team of researchers affiliated with the University of New Mexico assessed the effects of smoked cannabis on fatigue intensity levels in 3,922 subjects over a 3+ year period. Study participants self-administered cannabis at home and reported symptom changes in …
Foz do Iguaçu, Brazil: Cannabis microdosing is associated with cognitive and behavioral improvements in a patient with mnemonic and non-mnemonic Alzheimer’s disease (AD) symptoms, according to a case report published in the Journal of Medical Case Reports. An international team of investigators affiliated with The Federal University for Latin American Integration in Brazil and with John Hopkins University in Baltimore reported on the experimental …
Corvallis, OR: Frequent cannabis use is not associated with motivation loss in adults, according to data published in the Journal of Clinical and Experimental Neuropsychology. A team of researchers affiliated with Oregon State University assessed motivation and self-reported apathy in a cohort of regular (three times per week or more) cannabis users and controls (non-users). Investigators identified no significant group differences in self-reported apathy …
Bergen, Norway: Patients with Parkinson’s disease (PD) often report symptomatic benefits from the use of cannabis, according to survey data published in the journal Acta Neurologica Scandinavica. Norwegian investigators surveyed cannabis use patterns and related attitudes among PD patients. Consistent with prior surveys, they reported that a significant minority of PD patients consume cannabis for symptom relief. Respondents were most likely to report improvements in motor …
Manaus, Brazil: The administration of oral doses of CBD is ineffective at reducing the severity of restless legs syndrome (RLS) in patients with Parkinson’s disease (PD) and REM sleep behavior disorder (RBD), according to clinical trial data published in the journal Cannabis and Cannabinoid Research. Brazilian researchers compared the use of CBD versus a placebo over a 14-week period. Patients in the CBD arm …
DENVER (PRWEB) JULY 06, 2022 On January 23, 2022, Cannabis Training University (CTU) announced the launch of “Master of Cannabis,” a comprehensive training program for entrepreneurs and professionals in the marijuana industry. “The online cannabis career training program has been receiving high satisfaction scores from students,” said Karen Getchell, CTU’s Director of Content Development. “So far, students have given the course an average …
SAN DIEGO, CA, July 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® is collaborating with Hospital del Cruce to conduct the first study in Argentina on the efficiency of CBD as a treatment for …